Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 13, 2019 - Issue
Submit an article Journal homepage
178
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model

Oscar Olvera-Montaño1 Clinical Research Department, Laboratorios Sophia, SA De CV, Zapopan, Jalisco, MexicoORCID Iconhttps://orcid.org/0000-0003-2717-349X
ORCID Icon,
Leopoldo Baiza-Duran1 Clinical Research Department, Laboratorios Sophia, SA De CV, Zapopan, Jalisco, Mexico
,
Juan D Quintana-Hau2 Research and Development Department (CIS), Zapopan, Jalisco, Mexico
,
Mayra G Quiñonez-Alvarado2 Research and Development Department (CIS), Zapopan, Jalisco, Mexico
,
Wen Zeng3 Sichuan Primed Shines Bio-Tech Co, Ltd, Chengdu, Sichuan, People’s Republic of China
,
Li Gong3 Sichuan Primed Shines Bio-Tech Co, Ltd, Chengdu, Sichuan, People’s Republic of China
&
Patricia Muñoz-Villegas1 Clinical Research Department, Laboratorios Sophia, SA De CV, Zapopan, Jalisco, MexicoCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7559-1218
ORCID Icon show all
Pages 3813-3821 | Published online: 04 Nov 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.